In order to reflect the uniqueness of the product, he used two landscapes of the birthplace of the brand: Guilin Lijiang River and terraced fields, and described the birthplace in traditional Chinese painting style, thus showing the origin and nature of the product. The product packaging did not overemphasize the effect, but aroused emotional resonance. The scenery of Guilin is the back of the 20-yuan banknote familiar to Chinese consumers. Everyone has a cognition and familiar scene that appears on the product packaging to resonate well with consumers.

In 2011, Zhong Longsheng entered Visual Communication at the university and started working for many years. He has a new understanding of the value of design and realized the power of design in life and life. He believes that design has life, not physical meaning, that is to say, design is like human beings, it must have expression and emotion, and it must be injected with human-related plots, such as culture and local feelings. The work must not be divorced from life to be practical and has connotative value. In addition, good works must use design elements to create contradictions and collisions to make them full of life. For example, color and color, in his opinion, have a qualitative difference, color is a vital combination, and color is just material.

Guilin Sanjin Pharmaceutical Co., Ltd. is a pharmaceutical company that specializes in the research and production of Chinese medicine and natural medicine. It is also one of the earliest manufacturers of modern Chinese medicine preparations in China. The predecessor was Guilin Chinese Medicine Factory. It was founded in 1967 by the state Invest 190,000 yuan to prepare. Since 1985, by insisting on reform and innovation, relying on scientific and technological progress and scientific management, the company’s main economic indicators have increased at an average annual rate of about 30%. From a small traditional Chinese medicine workshop that was on the verge of bankruptcy, it has become a well-known modern Chinese medicine manufacturer. In 2007 The company completed sales revenue of 1.08 billion yuan and realized profits and taxes of 410 million yuan. Its main indicators have been ranked first in Guangxi's pharmaceutical industry for many years, and it has been ranked among the top 50 Chinese medicine industries in China.